Skip to search.
 TSX Down 0.45% TSX Ventures Down 0.77%

Opexa Therapeutics, Inc. (OPXA)

-NasdaqCM
3.22 Down 0.05(1.53%) 2:53PM EDT - Nasdaq Real Time Price
Prev Close:3.27
Open:3.28
Bid:3.22 x 500
Ask:3.25 x 200
1y Target Est:14.10
Beta:1.29729
Earnings Date:Nov 8 - Nov 14 (Est.)
Day's Range:3.19 - 3.34
52wk Range:1.69 - 5.10
Volume:28,762
Avg Vol (3m):73,700
Market Cap:22.70M
P/E (ttm):N/A
EPS (ttm):-1.37
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
OPXADown 1.53%22.70M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):9.02
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-1.12
Quarterly EPS Est (Sep-16) :-0.25
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Opexa Therapeutics, Inc., a biopharmaceutical company, develops personalized immunotherapy to treat multiple sclerosis (MS) and other autoimmune diseases based on its proprietary T-cell technology. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback